Results 121 to 130 of about 57,654 (328)

Preferences for COVID-19 vaccine: Evidence from India [PDF]

open access: yesarXiv, 2021
India's mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side effects, protection duration, distance to vaccination ...
arxiv  

Willingness to accept herpes zoster vaccines and the influencing factors in China

open access: yesBMC Infectious Diseases, 2022
Background Herpes zoster increases the burden on the elderly in an aging society. Although an effective vaccine licensed by China Food and Drug Administration in 2019 was introduced into the market in June 2020, the willingness and influencing factors of
Binshan Jiang   +7 more
doaj   +1 more source

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]

open access: yes, 2019
Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M   +4 more
core  

Universal Health Coverage for Schizophrenia: A Global Mental Health Priority. [PDF]

open access: yes, 2015
The growing momentum towards a global consensus on universal health coverage, alongside an acknowledgment of the urgency and importance of a comprehensive mental health action plan, offers a unique opportunity for a substantial scale-up of evidence-based
Patel, Vikram
core   +2 more sources

Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on Vaccination

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The immunosuppressive and immunomodulatory treatment of dermatological patients necessitates the regular review and updating of standard vaccinations and vaccines indicated for specific conditions. The German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute regularly publishes evidence‐based vaccination recommendations ...
Johanna Stoevesandt   +3 more
wiley   +1 more source

Understanding hesitancy with revealed preferences across COVID-19 vaccine types [PDF]

open access: yesarXiv, 2021
Many countries have secured larger quantities of COVID-19 vaccines than their populace is willing to take. This abundance and variety of vaccines created a historical moment to understand vaccine hesitancy better. Never before were more types of vaccines available for an illness and the intensity of vaccine-related public discourse is unprecedented ...
arxiv  

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

open access: yesJournal of Infectious Diseases, 2018
Background The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01B Adjuvant System, was highly efficacious in preventing herpes zoster in the ZOE-50 and ZOE-70 trials.
A. Cunningham   +22 more
semanticscholar   +1 more source

Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient [PDF]

open access: yes, 2016
A 79-year-old man with chronic lymphocytic leukaemia presented with fever and a widespread vesicular rash on 19 November 2014. The patient had not been under immunosuppressive regime for 6 months.
Breuer, J   +5 more
core   +1 more source

Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to evaluate the postmarketing safety of monoclonal antibodies (mAbs) targeting the calcitonin gene‐related peptide pathway used for migraine prophylaxis through pharmacovigilance data analysis by examining suspected adverse events reported in Europe.
Victoria Nikitina   +3 more
wiley   +1 more source

Nonparametric and adaptive modeling of dynamic seasonality and trend with heteroscedastic and dependent errors [PDF]

open access: yesarXiv, 2012
Seasonality (or periodicity) and trend are features describing an observed sequence, and extracting these features is an important issue in many scientific fields. However, it is not an easy task for existing methods to analyze simultaneously the trend and {\it dynamics} of the seasonality such as time-varying frequency and amplitude, and the {\it ...
arxiv  

Home - About - Disclaimer - Privacy